Dr
Center for Cancer Research and Cell Biology, Queen’s University Belfast, Northern Ireland Cancer Center, Belfast City Hospital, Belfast, Northern Ireland
Author in the following contributions
- Automated Bone Scan Index (aBSI) as an Imaging Biomarker in Castration Sensitive Metastatic Prostate Cancer in a novel clinical trial with Radium-223 and External Beam Radiotherapy
- Use of bone health agents (BHAs) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 after abiraterone: An interim review of REASSURE
- Radium-223 (Ra-223) therapy after abiraterone: analysis of symptomatic skeletal events (SSEs) in an international early access program (iEAP) in patients with metastatic castration-resistant prostate cancer (mCRPC)
- Mechanistic modelling of Radium-223 treatment of bone metastases
- In vitro radiobiological effects of Radium-223